GEODE CAPITAL MANAGEMENT, LLC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 123 filers reported holding ARRAY BIOPHARMA INC in Q1 2014. The put-call ratio across all filers is 3.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$139,239,000
+106.9%
3,005,394
+8.9%
0.03%
+100.0%
Q1 2019$67,306,000
-5.3%
2,760,761
-44.7%
0.02%
+54.5%
Q4 2018$71,098,000
+101.6%
4,989,452
+115.0%
0.01%
+10.0%
Q3 2018$35,270,000
-3.6%
2,320,411
+6.4%
0.01%
-9.1%
Q2 2018$36,589,000
+13.1%
2,180,551
+10.0%
0.01%0.0%
Q1 2018$32,339,000
+35.3%
1,981,611
+6.1%
0.01%
+37.5%
Q4 2017$23,906,000
+8.9%
1,867,750
+4.7%
0.01%0.0%
Q3 2017$21,943,000
+74.9%
1,784,045
+19.0%
0.01%
+60.0%
Q2 2017$12,548,000
-10.4%
1,499,178
-4.3%
0.01%
-16.7%
Q1 2017$14,000,000
+9.7%
1,566,152
+7.8%
0.01%0.0%
Q4 2016$12,767,000
+98.5%
1,452,520
+52.4%
0.01%
+100.0%
Q3 2016$6,433,000
+98.4%
953,180
+4.6%
0.00%
+50.0%
Q2 2016$3,242,000
+24.4%
910,869
+3.0%
0.00%
+100.0%
Q1 2016$2,607,000
-40.4%
883,950
-14.7%
0.00%
-50.0%
Q4 2015$4,373,000
+10.7%
1,036,436
+19.6%
0.00%0.0%
Q3 2015$3,950,000
-32.4%
866,247
+6.9%
0.00%
-33.3%
Q2 2015$5,840,000
-1.8%
810,079
+0.3%
0.00%0.0%
Q1 2015$5,950,000
+80.8%
807,374
+16.0%
0.00%
+50.0%
Q4 2014$3,291,000
+58.8%
695,843
+19.8%
0.00%
+100.0%
Q3 2014$2,073,000
-20.3%
580,949
+1.9%
0.00%
-50.0%
Q2 2014$2,600,000
-1.8%
570,348
+1.2%
0.00%0.0%
Q1 2014$2,649,000
-0.5%
563,781
+6.1%
0.00%0.0%
Q4 2013$2,661,000
-17.7%
531,183
+2.2%
0.00%
-33.3%
Q3 2013$3,233,000
+49.0%
519,794
+8.7%
0.00%
+50.0%
Q2 2013$2,170,000478,0580.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q1 2014
NameSharesValueWeighting ↓
Redmile Group, LLC 16,459,128$234,543,0009.43%
APIS CAPITAL ADVISORS, LLC 490,000$6,983,0009.36%
BVF INC/IL 4,744,062$67,603,0008.84%
First Light Asset Management, LLC 2,853,826$40,667,0006.48%
SECTORAL ASSET MANAGEMENT INC 2,165,767$30,862,0004.20%
GREAT POINT PARTNERS LLC 1,850,000$26,363,0003.33%
PACIFIC VIEW ASSET MANAGEMENT, LLC 146,952$2,092,0002.46%
Birchview Capital, LP 168,000$2,394,0002.26%
X-Square Capital, LLC 180,554$2,572,0002.02%
FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD 295,610$4,212,0001.54%
View complete list of ARRAY BIOPHARMA INC shareholders